COVID-19 vaccinations summary

Second Boosters Administered 1,073,025
Total Doses Administered 13,272,440
First Boosters Administered 2,779,285
Percentage of 12+ who have completed primary course 86.1%
Percentage of eligible 50+ who have received second booster 57.2%
Percentage of eligible 18+ who have received first booster 72.8%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

All data comes from the Aotearoa Immunisation Register (AIR). The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view. The person view includes all people that are currently alive and in AIR. On 12 June 2024, the estimated population was changed to be sourced from AIR instead of the most recent Health Service User (HSU).

Total Vaccinations

  Vaccinations last week Cumulative total
Primary Course Doses 175 8,020,529
Booster 1 241 2,779,285
Booster 2 2,557 1,073,025
Booster 3+ 20,223 967,763
Paediatric First Dose 23 272,481
Paediatric Second Dose 8 158,904
Infant First Dose 1 189
Infant Second Dose 2 139
Infant Third Dose 2 125
Total doses 23,232 13,272,440

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Sunday 09 June 2024.
  • Vaccinations last week:  Over the 7 days up to and including Sunday 09 June 2024.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 487 258,258 66,910
Pacific Peoples 251 156,345 29,113
Asian 956 468,113 65,879
European/Other 3,007 1,823,187 700,497
Unknown 9 17,724 3,355
Total 4,710 2,723,627 865,754

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
30 to 34 210,824 42,636 20.2%
35 to 49 642,901 131,540 20.5%
50 to 64 734,139 297,958 40.6%
65+ 779,947 567,796 72.8%

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation